JP2008532014A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008532014A5 JP2008532014A5 JP2007557159A JP2007557159A JP2008532014A5 JP 2008532014 A5 JP2008532014 A5 JP 2008532014A5 JP 2007557159 A JP2007557159 A JP 2007557159A JP 2007557159 A JP2007557159 A JP 2007557159A JP 2008532014 A5 JP2008532014 A5 JP 2008532014A5
- Authority
- JP
- Japan
- Prior art keywords
- useful
- epitopes
- epitopes according
- useful epitopes
- nisch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 201000010099 disease Diseases 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
- 230000027455 binding Effects 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 239000013610 patient sample Substances 0.000 claims 3
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 206010041067 Small cell lung cancer Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 238000002493 microarray Methods 0.000 claims 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 239000000523 sample Substances 0.000 claims 2
- 208000000587 small cell lung carcinoma Diseases 0.000 claims 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 2
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 claims 1
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 claims 1
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 claims 1
- 101000603223 Homo sapiens Nischarin Proteins 0.000 claims 1
- 102100031413 L-dopachrome tautomerase Human genes 0.000 claims 1
- 101710093778 L-dopachrome tautomerase Proteins 0.000 claims 1
- 102100038995 Nischarin Human genes 0.000 claims 1
- 101710173694 Short transient receptor potential channel 2 Proteins 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 238000004393 prognosis Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65685905P | 2005-02-24 | 2005-02-24 | |
| PCT/US2006/006431 WO2006091734A2 (en) | 2005-02-24 | 2006-02-24 | Compositions and methods for classifying biological samples |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008532014A JP2008532014A (ja) | 2008-08-14 |
| JP2008532014A5 true JP2008532014A5 (cg-RX-API-DMAC7.html) | 2009-04-16 |
Family
ID=36928007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007557159A Withdrawn JP2008532014A (ja) | 2005-02-24 | 2006-02-24 | 生物試料を分類するための組成物及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20090075832A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1859266A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008532014A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080003321A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101160524A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006216683A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2598889A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL185458A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007010349A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2007135030A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006091734A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060222656A1 (en) | 2005-04-01 | 2006-10-05 | University Of Maryland, Baltimore | MAGE-A3/HPV 16 peptide vaccines for head and neck cancer |
| WO2002094994A2 (en) | 2001-05-18 | 2002-11-28 | Mayo Foundation For Medical Education And Research | Chimeric antigen-specific t cell-activating polypeptides |
| EP2502628B1 (en) * | 2006-06-23 | 2016-12-14 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in cancer |
| WO2008053573A1 (fr) | 2006-10-30 | 2008-05-08 | National University Corporation Hokkaido University | Remède pour néoplasme malin |
| TWI494319B (zh) * | 2007-02-21 | 2015-08-01 | Oncotherapy Science Inc | 表現腫瘤相關抗原之癌症的胜肽疫苗 |
| WO2009029716A1 (en) * | 2007-08-28 | 2009-03-05 | Ramot At Tel Aviv University | Peptides inducing a cd4i conformation in hiv gp120 while retaining vacant cd4 binding site |
| TWI466680B (zh) * | 2008-08-01 | 2015-01-01 | Oncotherapy Science Inc | Ｍｅｌｋ抗原決定位胜肽及含此胜肽的疫苗 |
| TW201008574A (en) | 2008-08-19 | 2010-03-01 | Oncotherapy Science Inc | INHBB epitope peptides and vaccines containing the same |
| US9855291B2 (en) | 2008-11-03 | 2018-01-02 | Adc Therapeutics Sa | Anti-kidney associated antigen 1 (KAAG1) antibodies |
| GB0823366D0 (en) * | 2008-12-22 | 2009-01-28 | Uni I Oslo | Synthesis |
| KR101067815B1 (ko) * | 2009-02-05 | 2011-09-27 | 서울대학교산학협력단 | 제1형 당뇨병의 신규한 진단 마커 |
| MX2012001746A (es) | 2009-08-14 | 2012-03-21 | Univ California | Metodos de diagnostico y tratamiento de autismo. |
| US8075895B2 (en) * | 2009-09-22 | 2011-12-13 | Janssen Pharmaceutica N.V. | Identification of antigenic peptides from multiple myeloma cells |
| TWI485245B (zh) | 2010-01-25 | 2015-05-21 | Oncotherapy Science Inc | 經修飾之ｍｅｌｋ胜肽及含此胜肽之疫苗 |
| SMT201900505T1 (it) | 2011-03-31 | 2019-11-13 | Adc Therapeutics Sa | Anticorpi contro l'antigene 1 associato ai reni e loro frammenti leganti l'antigene |
| US10060911B2 (en) * | 2011-08-19 | 2018-08-28 | Protagen Aktiengesellschaft | Method for diagnosis of high-affinity binders and marker sequences |
| WO2013031757A1 (ja) * | 2011-08-29 | 2013-03-07 | 東レ株式会社 | 膵癌、乳癌、肺癌又は前立腺癌の検出用マーカー及び検査方法 |
| CA2857400A1 (en) | 2012-01-09 | 2013-07-18 | Alethia Biotherapeutics Inc. | Anti-kaag1 antibodies or antigen binding fragment thereof for treatment of triple negative breast cancer |
| US20130183242A1 (en) * | 2012-01-18 | 2013-07-18 | University Of Connecticut | Methods for identifying tumor-specific polypeptides |
| GB201319446D0 (en) | 2013-11-04 | 2013-12-18 | Immatics Biotechnologies Gmbh | Personalized immunotherapy against several neuronal and brain tumors |
| WO2015172843A1 (en) | 2014-05-16 | 2015-11-19 | Biontech Diagnostics Gmbh | Methods and kits for the diagnosis of cancer |
| EP3145516A4 (en) * | 2014-05-20 | 2018-06-13 | Kiromic, LLC | Methods and compositions for treating malignancies with dendritic cells |
| EP3247407A4 (en) | 2015-01-21 | 2018-08-22 | Inhibrx LP | Non-immunogenic single domain antibodies |
| GB201505305D0 (en) * | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
| WO2016210137A1 (en) | 2015-06-26 | 2016-12-29 | The Regents Of The University Of California | Antigenic peptides and uses thereof for diagnosing and treating autism |
| SI3322734T1 (sl) | 2015-07-16 | 2021-02-26 | Inhibrx, Inc. | Multivalentni in multispecifični DR5-vezavni fuzijski proteini |
| MY198087A (en) * | 2015-10-05 | 2023-07-31 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| EP3193173A1 (en) * | 2016-01-14 | 2017-07-19 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Serological autoantibodies as biomarker for colorectal cancer |
| GB201604458D0 (en) * | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against cancers |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
| AU2018212584B2 (en) * | 2017-01-27 | 2020-12-10 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| CN108948184B (zh) * | 2017-05-22 | 2021-04-23 | 香雪生命科学技术（广东）有限公司 | 一种识别衍生自prame抗原短肽的t细胞受体 |
| CN109400697B (zh) * | 2017-08-17 | 2021-04-23 | 香雪生命科学技术（广东）有限公司 | 一种识别prame抗原短肽的tcr及其相关组合物 |
| EP3756680A1 (en) * | 2019-06-26 | 2020-12-30 | Universitat de Lleida | Intermediate filament-derived peptides and their uses |
| WO2021011636A1 (en) * | 2019-07-15 | 2021-01-21 | Geisinger Health | COMPOSITIONS AND METHODS OF TREATMENT FOR BREAST CANCER INVOLVING A NOVEL CAPERα-MLL1 COMPLEX |
| CN110922492B (zh) * | 2019-12-18 | 2022-02-15 | 重庆医科大学 | 融合肽、ctp介导的诱导cml细胞免疫应答的dc疫苗及其制备方法 |
| CN111337678B (zh) * | 2020-02-21 | 2023-06-06 | 杭州凯保罗生物科技有限公司 | 与肿瘤免疫治疗效果相关的生物标志物及其应用 |
| CN116773798A (zh) * | 2023-06-16 | 2023-09-19 | 北京三品医疗科技有限公司 | 多肽的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7625697B2 (en) * | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
| US20030092009A1 (en) * | 2000-11-16 | 2003-05-15 | Kaia Palm | Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease |
| WO2002073209A2 (de) * | 2001-03-10 | 2002-09-19 | Affina Immuntechnik Gmbh | Verfahren zur identifikation von immunreaktiven epitopen auf proteinen |
| EP1386155A4 (en) * | 2001-04-10 | 2006-05-10 | Univ Leland Stanford Junior | THERAPEUTIC AND DIAGNOSTIC USE OF ANTIBODY SPECIFICITY PROFILES |
| WO2003042357A2 (en) * | 2001-09-28 | 2003-05-22 | Incyte Genomics, Inc. | Enzymes |
| EP1578970A1 (de) * | 2002-12-23 | 2005-09-28 | Hans-Jürgen Thiesen | Human-autoantigene und deren verwendung |
| US20040219575A1 (en) * | 2002-12-26 | 2004-11-04 | Toomas Neuman | Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
-
2006
- 2006-02-24 AU AU2006216683A patent/AU2006216683A1/en not_active Abandoned
- 2006-02-24 CA CA002598889A patent/CA2598889A1/en not_active Abandoned
- 2006-02-24 KR KR1020077021910A patent/KR20080003321A/ko not_active Withdrawn
- 2006-02-24 EP EP06735911A patent/EP1859266A4/en not_active Withdrawn
- 2006-02-24 CN CNA2006800126573A patent/CN101160524A/zh active Pending
- 2006-02-24 MX MX2007010349A patent/MX2007010349A/es not_active Application Discontinuation
- 2006-02-24 WO PCT/US2006/006431 patent/WO2006091734A2/en not_active Ceased
- 2006-02-24 US US11/817,010 patent/US20090075832A1/en not_active Abandoned
- 2006-02-24 RU RU2007135030/15A patent/RU2007135030A/ru not_active Application Discontinuation
- 2006-02-24 JP JP2007557159A patent/JP2008532014A/ja not_active Withdrawn
-
2007
- 2007-08-22 IL IL185458A patent/IL185458A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008532014A5 (cg-RX-API-DMAC7.html) | ||
| RU2007135030A (ru) | Композиции и способы классификации биологических образцов | |
| JP7531217B2 (ja) | 癌を査定および／または処置するためのセルフリーｄｎａ | |
| van Buuren et al. | Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection | |
| Borie et al. | Clinical characteristics and prognostic factors of pulmonary MALT lymphoma | |
| Landt et al. | ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia | |
| CN103826750B (zh) | 从血液中捕获和检测循环多发性骨髓瘤的测定法 | |
| JP2012508865A5 (cg-RX-API-DMAC7.html) | ||
| Wirth et al. | A case study of salivary microbiome in smokers and non-smokers in Hungary: analysis by shotgun metagenome sequencing | |
| JP2009522578A5 (cg-RX-API-DMAC7.html) | ||
| Mok et al. | Association of kidney disease measures with cause-specific mortality: the Korean Heart Study | |
| Los-de Vries et al. | Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV | |
| Batistatou et al. | Evaluation of current prognostic and predictive markers in breast cancer: a validation study of tissue microarrays | |
| TW201840854A (zh) | 準確診斷牙科疾病的方法與設備 | |
| JP2015518152A (ja) | 前立腺がんの検出用バイオマーカーの定量 | |
| EP3022561A1 (en) | Method for the prognosis of survival time of a patient suffering from a solid cancer | |
| JP2008502332A5 (cg-RX-API-DMAC7.html) | ||
| JP2007508527A5 (cg-RX-API-DMAC7.html) | ||
| Catlett et al. | Primary lymphoma of bone: an institutional experience | |
| Huang et al. | Aneuploid circulating tumor cells as a predictor of response to neoadjuvant chemotherapy in non-small cell lung cancer | |
| JP2016531596A (ja) | 循環している癌のバイオマーカー及びその使用 | |
| Maeshima et al. | Clinicopathological characteristics of diffuse large B-cell lymphoma involving small and large intestines: an analysis of 126 patients | |
| Benhammou et al. | DETECT: development of technologies for early HCC detection | |
| Andreadis et al. | Metastatic renal clear cell carcinoma in the parotid gland: a study of immunohistochemical profile and cell adhesion molecules (CAMs) expression in two cases | |
| TW201926094A (zh) | 三陰性乳癌的次分類及方法 |